Molecular Imaging

Research Article

Preliminary Assessment of Reference Region Quantification and Reduced Scanning Times for [18F]SynVesT-1 PET in Parkinson’s Disease

Table 1

Participant and scan characteristics.
Healthy controlParkinson’s disease
( male)3 (2)5 (4)
Age (years)0.11
Disease duration (years)——
LEDD (mg)——
MDS-UPDRSIII score——
Hoehn and Yahr scale score——
Injected activity (MBq)0.91
Molar activity (MBq/nmol)0.39
Plasma free fraction0.34
values from independent samples -tests comparing HC to PD. Values represent group . Abbreviations: LEDD: L-Dopa equivalent daily dose; MDS-UPDRSIII: Movement Disorders Society-Unified Parkinson’s Disease Rating Scale, part III motor assessment.